During the past decade, MHAT for Womens Health - Nadezhda OOD conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MHAT for Womens Health - Nadezhda OOD" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "G1 Therapeutics, Inc." with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Celcuity, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT for Womens Health - Nadezhda OOD" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "MHAT for Womens Health - Nadezhda OOD" are "Breast Cancer" (6 trials), "Breast Neoplasm" (3 trials), "Carcinoma, Ductal, Breast" (2 trials), "Triple-Negative Breast Cancer" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "MHAT for Womens Health - Nadezhda OOD" in a lesser frequency.

Most popular intervention types in "MHAT for Womens Health - Nadezhda OOD" are "Drug" (14 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Paclitaxel" (5 trials), "Placebo" (4 trials), "Cisplatin" (3 trials) and "Fulvestrant" (3 trials). Other intervention names were less common.

The vast majority of trials in "MHAT for Womens Health - Nadezhda OOD" are 10 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "MHAT for Womens Health - Nadezhda OOD". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in MHAT for Womens Health - Nadezhda OOD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MHAT for Womens Health - Nadezhda OOD, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".